During the past decade, Hôpital Habib Bourguiba conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Habib Bourguiba" #1 sponsor was "Imara, Inc." with 2 trials, followed by "Laboratoire français de Fractionnement et de Biotechnologies" with 2 trials sponsored, "Biogen" with 1 trials sponsored, "Groupe Oncologie Radiotherapie Tete et Cou" with 1 trials sponsored and "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Habib Bourguiba" #1 collaborator was "Institut des Maladies Rares" with 1 trials as a collaborator and "National Research Agency, France" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Habib Bourguiba" are "Chronic Inflammatory Demyelinating Polyradiculoneuropathy" (2 trials), "Cerebellar Ataxias" (1 trials), "Diarrhea" (1 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Nasopharyngeal Cancers" (1 trials). Many other conditions were trialed in "Hôpital Habib Bourguiba" in a lesser frequency.

Most popular intervention types in "Hôpital Habib Bourguiba" are "Drug" (6 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "I10E" (2 trials), "IMR-687" (2 trials), "Placebo" (2 trials), "BIIB017 (peginterferon beta-1a)" (1 trials) and "Diosmectite (Smecta®)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Habib Bourguiba" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Habib Bourguiba". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hôpital Habib Bourguiba, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Habib Bourguiba, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".